NCT01647750View on ClinicalTrials.gov

Study of Optimal Replacement of Thyroxine in the Elderly

PHASE4CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

August 31, 2012

Primary Completion Date

August 31, 2014

Study Completion Date

August 31, 2014

Conditions
Hypothyroidism
Interventions
DRUG

Levothyroxine

Participants in the lower dose arm of the study will receive a lower dose of levothyroxine than their usual dose

DRUG

Levothyroxine

Participants in the standard dose of treatment will receive their usual dose of levothyroxine

Trial Locations (2)

NE8 4YL

Bensham Hospital, Gateshead

NE1 4LP

Clinical Research Facility, Newcastle upon Tyne

All Listed Sponsors
collaborator

National Institute for Health Research, United Kingdom

OTHER_GOV

lead

Newcastle-upon-Tyne Hospitals NHS Trust

OTHER

NCT01647750 - Study of Optimal Replacement of Thyroxine in the Elderly | Biotech Hunter | Biotech Hunter